Author:
Liu Keyue,Yorozuya Toshihiro,Adachi Naoto,Motoki Atsuko,Ninomiya Kanji,Mabuchi Hisao,Iwamoto Noriyuki,Nishibori Masahiro
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference18 articles.
1. Nakamura S, Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol. 2004;24:502–5.
2. Numata M, Nakayama M, Hosoya T, Hoff CM, Holmes CJ, Schalling M, Nordfors L, Lindholm B. Possible pathologic involvement of receptor for advanced glycation end products (RAGE) for development of encapsulating peritoneal sclerosis in Japanese CAPD patients. Clin Nephrol. 2004;62:455–60.
3. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 1998;161:2586–93.
4. Hirasawa N, Ohuchi K, Watanabe M, Tsurufuji S. Role of endogenous histamine in postanaphylactic phase of allergic inflammation in rats. J Pharmacol Exp Ther. 1987;241:967–73.
5. Tanaka S, Ichikawa A. Recent advances in molecular pharmacology of the histamine systems: immune regulatory roles of histamine produced by leukocytes. J Pharmacol Sci. 2006;101:19–23.